Rehabilitation Sciences Institute, University of Toronto, Toronto, Canada.
Toronto Rehabilitation Institute-University Health Network, Swallowing Rehabilitation Research Laboratory, Toronto, Canada.
Otolaryngol Head Neck Surg. 2022 Mar;166(3):511-514. doi: 10.1177/01945998211010435. Epub 2021 May 4.
The current standard for the treatment of oropharynx cancers is radiation therapy. However, patients are frequently left with dysphagia characterized by penetration-aspiration (impaired safety) and residue (impaired efficiency). Although thickened liquids are commonly used to manage dysphagia, we lack evidence to guide the modification of liquids for clinical benefit in the head and neck cancer population. The objective of this study was to assess the impact of slightly and mildly thick liquids on penetration-aspiration and residue in 12 patients with oropharyngeal cancer who displayed penetration-aspiration on thin liquid within 3 to 6 months after completion of radiotherapy. Significantly fewer instances of penetration-aspiration were seen with slightly and mildly thick liquids as compared with thin ( < .05). No differences were found across stimuli in the frequency of residue. Patients with oropharyngeal cancers who present with post-radiation therapy dysphagia involving penetration-aspiration on thin liquids may benefit from slightly and mildly thick liquids without risk of worse residue.
目前治疗口咽癌的标准方法是放射疗法。然而,患者经常会出现吞咽困难的情况,表现为(安全性受损的)渗透-吸入和(效率受损的)残留。尽管常常用增稠液体来治疗吞咽困难,但我们缺乏指导头颈癌患者调整液体以获得临床获益的证据。本研究的目的是评估在放疗后 3 至 6 个月内,对 12 例存在口咽癌且在稀薄液体中出现渗透-吸入的患者,稍微和轻度增稠液体对渗透-吸入和残留的影响。与稀薄液体相比,稍微和轻度增稠液体的渗透-吸入次数明显减少(<0.05)。在刺激物之间,残留的频率没有差异。在接受放射治疗后出现与稀薄液体相关的渗透-吸入的吞咽困难的口咽癌患者,使用稍微和轻度增稠液体可能会受益,而不会增加残留的风险。